HF006
The percentage of patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction, who are currently treated with a beta-blocker licensed for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF004 | 2019 | 102 | 114 | 89.5% | |
| HF004 | 2020 | 102 | 114 | 89.5% | |
| HF006 | 2021 | 138 | 162 | 85.2% | |
| HF006 | 2022 | 197 | 212 | 92.9% | |
| HF006 | 2023 | 197 | 207 | 95.2% |
